![]() |
|
|
Laboratory of Medicinal Chemistry (G.S.A., J.S.D.,
D.G.J.),
Division of Basic Sciences, Experimental
Retrovirology Branch (W.-Y.G.), Division of Clinical
Sciences, National Cancer Institute; and
Biomedical
Engineering and Instrumentation Program (R.L.D.,
P.F.M.), National Center for Research Resources, National
Institutes of Health
Measurement of intracellular drug levels in cell culture systems
can be of predictive value in establishing rational clinical dosage
schedules. Such in vitro measurements carried out with anti-HIV agents of the 2
,3
-dideoxynucleoside (ddN) class have shown
that many of the pharmacologically active ddNTP metabolites of these
agents have relatively long intracellular half-lives and little or no
host-cell cytotoxicity. As a consequence, replication of drug-exposed
cells continues at an unperturbed rate so that a systematic dilution
error occurs in the measurement of ddNTP decay half-times. The aim of
this study is to present a simple general formulation for the
correction of measured t1/2-values for ddNTPs
and for other agents with similar intracellular pharmacokinetic properties. Two factors of practical interest emerge: first, the error
is greater for agents with slow intracellular clearance rates than for
agents with rapid rates; and second, for cell lines with long doubling
times, the measured t1/2-values approach more closely to the true t1/2-values, until with the
extreme case (quiescent or "G0" cells), the
observed and true decay times are identical. The greatest dilution
errors are seen with adenodine-based agents such as ddATP and
2
-F-ddATP, while the smallest errors are seen with rapidly cleared
agents of the dideoxythymidine class.